RIPK1 and central nervous system cancer: We found that the expression of genetic signatures of different lymphocyte populations, i.e., helper, cytotoxic, memory, and regulatory T cells, was upregulated in the mIDH gliomas with high RIPK1 expression levels (Figure 5A).